Journal of Enzyme Inhibition and Medicinal Chemistry 2013-02-01

Synthesis and biological evaluation of novel benzothiazole clubbed fluoroquinolone derivatives.

Prabodh Chander Sharma, Ravinder Kumar, Monika Chaudhary, Archana Sharma, Harish Rajak

Index: J. Enzyme Inhib. Med. Chem. 28(1) , 1-10, (2013)

Full Text: HTML

Abstract

In the present investigation, synthesis and anti-bacterial, analgesic and anthelmintic evaluation of a novel series of fluoroquinolone derivatives clubbed with benzothiazole moeity has been described. The synthesized compounds were characterised by spectral analysis (IR and (1)H NMR). Preliminary results indicated that the most of the synthesized compounds demonstrated good activities against gram negative and gram positive bacterial strains. Compounds 5a, 5b, 5f and 5k demonstrated potent anti-bacterial activities. Compound 5a exhibited most potent anti-bacterial activity with MIC values of 04, 03, 08 and 15 µg/ mL against B. subtilis, S. aureus, E. coli and P. aeruginosa. Analogs 5a, 5c, 5g and 5h showed promising anthelmintic activity against Eisemia foetida in a low concentration as compared to standard drug piperazine citrate with mean paralysis time ranging 22.60 ± 2.46 to 31.60 ± 3.07 min. All synthesized compounds depicted good in vivo analgesic activity with compound 5a exhibiting the most potent activity of 55.19% inhibition of writhing in comparison to the standard drug.


Related Compounds

Related Articles:

Endogenous formation of N-nitrosamines from piperazine and their urinary excretion following antihelmintic treatment with piperazine citrate.

1991-09-01

[Carcinogenesis 12(9) , 1595-9, (1991)]

Some effects of piperazine citrate on skeletal muscle and central nervous system.

1987-11-01

[Arch. Int. Pharmacodyn. Ther. 290(1) , 104-16, (1987)]

Treatment of helminthic diseases.

1985-09-01

[Am. Fam. Physician 32(3) , 182-8, (1985)]

Management of intestinal obstruction caused by ascariasis.

1997-04-01

[J. Pediatr. Surg. 32(4) , 585-7, (1997)]

Occupational asthma due to piperazine citrate.

2006-01-01

[J. Investig. Allergol. Clin. Immunol. 16(2) , 138-9, (2006)]

More Articles...